PRACTICAL AND HOT TOPICS

Monday, February 27, 2023

3:52 PM – 5:45 PM ET

Moderator(s)

ME

Marvin Eng, MD

Structural Heart Disease Medical Director
Banner University Medical Center
Phoenix, Arizona, United States

Disclosure(s): Edwards Lifesciences LLC: Speakers' Bureau (Ongoing)
Howard C. Herrmann, MD, FACC, MSCAI

Director, Interventional Cardiology and Cardiac Cath Labs
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States

Disclosure(s): Abbott Vascular, Edwards, Medtronic, Boston Scientific: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Highlife Medical: Contracted Research (Ongoing); Holistick Medical: Stock Shareholder (excluding mutual funds) (Ongoing); Innovalve: Grant/Research Support (Ongoing); medtronic: Consultant (Ongoing); Microinterventional Devices: Consulting Fees (e.g., advisory boards) (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Wells Fargo: Consulting Fees (e.g., advisory boards) (Ongoing); WL Gore & Associates: Consulting fees or other remuneration (Ongoing), Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing)
Robert J. Widmer, MD, PhD (he/him/his)

Director Interventional Cath Labs
Baylor Scott & White Health
Belton, Texas, United States

Disclosure(s): Abbot Vascular: Consultant/Advisory Board (Ongoing), Fees for Non-CME Services Received Directly from Commercial Interest or their Agents (e.g., speakers' bureaus) (Ongoing); Philips-Spectranetics: Consultant/Advisory Board (Ongoing)

Disclosure(s):

Marvin Eng, MD: Edwards Lifesciences LLC: Speakers' Bureau (Ongoing)

Howard C. Herrmann, MD, FACC, MSCAI: Abbott Vascular, Edwards, Medtronic, Boston Scientific: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Highlife Medical: Contracted Research (Ongoing); Holistick Medical: Stock Shareholder (excluding mutual funds) (Ongoing); Innovalve: Grant/Research Support (Ongoing); medtronic: Consultant (Ongoing); Microinterventional Devices: Consulting Fees (e.g., advisory boards) (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Wells Fargo: Consulting Fees (e.g., advisory boards) (Ongoing); WL Gore & Associates: Consulting fees or other remuneration (Ongoing), Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing)

Robert J. Widmer, MD, PhD: Abbot Vascular: Consultant/Advisory Board (Ongoing), Fees for Non-CME Services Received Directly from Commercial Interest or their Agents (e.g., speakers' bureaus) (Ongoing); Philips-Spectranetics: Consultant/Advisory Board (Ongoing)